Search

1 to 10 of 340
Sort by

Library Entry
SITC Clinical Practice Guideline Webinar - Practical Management Pearls for Immune Checkpoint Inhibitor-related Adverse Events - Recorded Webinar and Presentation Slides

On September 16, 2021, leading experts from the SITC Immune Checkpoint Inhibitor-related Adverse Events Guideline Expert Panel presented the "SITC Clinical Practice Guideline Webinar – Practical Management Pearls for Immune Checkpoint Inhibitor-related Adverse Events." This high-level webinar...

2 attachments


Library Entry
Immunotherapy for the Treatment of Urothelial Cancer Guideline Overview – SITC CPG Webinar Recording and Presentation Slides

On August 25, 2021, leading experts in cancer immunotherapy presented an overview of the publication "Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of urothelial cancer" during a live webinar. The recorded webinar and presentation...

2 attachments


Library Entry
SITC CPG Webinar - Practical Management Pearls for Immune Effector Cell-related Adverse Events - Recorded Webinar and Presentation Slides

On August 12, 2021, leading experts from the SITC Immune Effector Cell-related Adverse Events Guideline Expert Panel presented the "SITC Clinical Practice Guideline Webinar – Practical Management Pearls for Immune Effector Cell-related Adverse Events." This high-level webinar covered advanced...

2 attachments


Library Entry
SITC Clinical Practice Guideline Webinar – Immune Checkpoint Inhibitor-related Adverse Events: Recorded Webinar and Presentation Slides

On August 13, 2021, leading experts in cancer immunotherapy presented an overview of the publication "Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events" during a live webinar. The recorded webinar and presentation...

2 attachments




Library Entry
SITC Clinical Practice Guideline: Immune Effector Cell-related Adverse Events - Recorded Webinar and Presentation Slides

On March 5, 2021, leading experts in cancer immunotherapy presented an overview of the publication "Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune effector cell-related adverse events" during a live webinar. The recorded webinar and presentation slides are...

2 attachments




Library Entry
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune effector cell-related adverse events

Immune effector cell (IEC) therapies offer durable and sustained remissions in significant numbers of patients with hematological cancers. While these unique immunotherapies have improved outcomes for pediatric and adult patients in a number of disease states, as ‘living drugs,’ their toxicity...